![Amy E. Tapper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy E. Tapper
Corporate Officer/Principal bei
IMAGO BIOSCIENCES, INC.
Profil
Amy E.
Tapper is a professional with a doctorate degree from Boston University and an undergraduate degree from Boston College.
She is currently the Senior VP-Chemistry, Manufacturing & Controls at Imago BioSciences, Inc. She was previously the Senior Vice President at FerroKin BioSciences, Inc. from 2008 to 2012.
Aktive Positionen von Amy E. Tapper
| Unternehmen | Position | Beginn |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.10.2012 |
Ehemalige bekannte Positionen von Amy E. Tapper
| Unternehmen | Position | Ende |
|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Amy E. Tapper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Wählen Sie MarketScreener 
